CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases

被引:69
|
作者
Lu, Qiang [1 ]
Cao, Wei [2 ]
Huang, Lijun [1 ]
Wan, Yi [3 ,4 ]
Liu, Tonggang [5 ]
Cheng, Qingshu [1 ]
Han, Yong [1 ]
Li, Xiaofei [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Intervent Radiol, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China
[4] Fourth Mil Med Univ, Inst Hlth Informat, Xian 710032, Peoples R China
[5] Fourth Mil Med Univ, Tangdu Hosp, Dept Resp, Xian 710032, Peoples R China
关键词
Percutaneous microwave coagulation therapy; Inoperable pulmonary malignancies; Survival rates; RADIOFREQUENCY ABLATION; LUNG MALIGNANCIES; FOLLOW-UP; THERAPY; RESECTION; CANCER; LIVER;
D O I
10.1186/1477-7819-10-80
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Microwave ablation (MWA) has attracted a worldwide attention gradually in treating inoperable pulmonary malignancies. However, in the lung tissues treated with MWA recurrence of tumor may still occur and few data in large patient groups till now were reported about the safety or effectiveness of microwave ablation in treating primary lung cancer and metastatic pulmonary malignancies. The purpose of this study is to evaluate the clinical curative effect (local control, survival data) MWA and its safety as well. Methods: From 1 January 2005 to 1 January 2008, retrospective analyses, 69 patients underwent computed tomography (CT)-guided percutaneous MWA of pulmonary malignancies. All patients were deemed medically inoperable. The correlation of tumor sizes and local progression after ablation was analyzed and the survival rates within 3 years post surgery were compared between non-small-cell lung cancer and pulmonary metastases groups also. Results: Pneumothorax was the most frequent complication and occurred in 24.64% patients after ablation. Neither needle track implantation was found nor did patient death occur in these patients within 30 days. The 1-, 2-, and 3-year overall survival rates were 66.7%, 44.9% and 24.6%, respectively. The overall survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 75.0%, 54.2%, and 29.2%, respectively. The overall survival rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 23.8%, and 14.3%, respectively. The recurrence-free survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 72.9%, 50.0%, and 27.1%, respectively. The mortality rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 19.0%, and 14.3%, respectively. Conclusions: Percutaneous microwave coagulation therapy was one safe and effective method and could be beneficial for the improvement of inoperable pulmonary malignancies treatment effect.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] CT-guided percutaneous microwave ablation for pulmonary metastases from colorectal cancer: Prognosis analyses based on the origin of the primary tumor
    Huang, Yuting
    Wu, Ketong
    Liu, Yang
    Li, Dan
    Lai, Haiyang
    Peng, Tao
    Wan, Yuan
    Zhang, Bo
    JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY, 2023, 31 (05) : 1001 - 1011
  • [32] CT-guided percutaneous radiofrequency ablation of spinal osteoid osteoma
    Liu Chen
    Liu Xiao-guang
    Zhu Bin
    Yuan Hui-shu
    Han Song-bo
    Ma Yong-qiang
    CHINESE MEDICAL JOURNAL, 2011, 124 (23) : 4083 - 4085
  • [33] CT-guided percutaneous radiofrequency ablation of spleen: A preliminary study
    Matsuoka, Toshiyuki
    Yamamoto, Akira
    Okuma, Tomohisa
    Oyama, Yoshimasa
    Nakamura, Kenji
    Inoue, Yuichi
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (04) : 1044 - 1046
  • [34] CT-guided percutaneous radiofrequency ablation of spinal osteoid osteoma
    LIU ChenLIU XiaoguangZHU BinYUAN HuishuHAN Songbo and MA Yongqiang Department of RadiologyPeking University Third Hospital Beijing China Department of OrthopedicsPeking University Third Hospital Beijing China
    中华医学杂志(英文版), 2011, (23) : 4083 - 4085
  • [35] Percutaneous CT-guided thermal ablation of primary lung cancer
    Konstantelou, Elissavet
    Hardavella, Georgia
    Assi, Avraam
    Dimitrakopoulou, Marianna
    Kosma, Aikaterini
    Liano, Evangelos
    Fergadi, Evangelos
    Ntokou, Anna
    Charalampakis, Nikolaos
    Kontis, Elissaios
    Karampinis, Ioannis
    Bolanos, Nikolaos
    Zias, Nikolaos
    Kosmas, Christos
    Stefanidis, Konstantinos
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [36] CT-guided percutaneous RF-ablation of osteoid osteoma
    Woertler, K
    Lindner, N
    Vestring, T
    Boettner, F
    Winkelmann, W
    Heindel, WL
    RADIOLOGY, 2000, 217 : 528 - 528
  • [37] PERCUTANEOUS CT-GUIDED RADIOFREQUENCY ABLATION FOR NSCLC: PRELIMINARY REPORT
    Zhang, Yi
    Zhi, Xiuyi
    Liu Baodong
    Hu, Mu
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S863 - S864
  • [38] CT-guided percutaneous radiofrequency ablation of osteoid osteoma in pregnancy
    Akhlaghpoor, Shahram
    Tomasian, Anderanik
    Shabestari, Abbas Arjmand
    Alinaghizadeh, Mohammad Reza
    CURRENT ORTHOPAEDIC PRACTICE, 2011, 22 (04): : 362 - 363
  • [39] Percutaneous lung and liver CT-guided ablation on swine model using microwave ablation to determine ablation size for clinical practice
    Habert, Paul
    Di Bisceglie, Mathieu
    Hak, Jean-Francois
    Brige, Pauline
    Chopinet, Sophie
    Mancini, Julien
    Bartoli, Axel
    Vidal, Vincent
    Roux, Charles
    Tselikas, Lambros
    De Baere, Thierry
    Gaubert, Jean-Yves
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2021, 38 (01) : 1140 - 1148
  • [40] Safety of CT-Guided Microwave Ablation of Subcardiac Liver Tumors
    Johnson, William
    Weekley, Adam
    Suz, Pilar
    Parikh, Nainesh
    El-Haddad, Ghassan
    Mhaskar, Rahul
    Kis, Bela
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 45 (11) : 1693 - 1700